跳至主要内容
临床试验/NCT04983706
NCT04983706Unknown不适用

An Exploratory Study of Optimizing the Core Number and Location for MRI/Ultrasound Fusion Targeted Prostate Biopsy

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年7月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
The significant prostate cancer detection rate with different combinations of core number and location in the targeted saturated biopsy area

研究概览

简要总结

This study aims to investigate the effect of core number and location optimization for targeted prostate biopsy on pathological accuracy.

详细描述

This is a single-center prospective study. The investigators perform MRI/US image fusion targeted saturation biopsy on prostate lesions with PI-RADS score 4, to investigate the effect of core number and location optimization for targeted prostate biopsy on pathological accuracy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Men more than 18 years old with clinical suspicion of prostate cancer;
  • •Serum PSA ≤ 20 ng/ml within the previous 3 months;
  • •No evidence of PSA increase by noncancerous factors, such as catheterization, bladder stones, or urinary tract infection including bacterial prostatitis;
  • •mpMRI PI-RADS V2.1 score ≥4, diameter of ≤2.5 cm;
  • •Able to provide written informed consent.

排除标准

  • •Prior prostate biopsy or prostate surgery;
  • •Prior treatment for prostate cancer;
  • •Contraindication to MRI (e.g. claustrophobia, pacemaker);
  • •Contraindication to prostate biopsy;
  • •Men in whom artifact would reduce the quality of the MRI.

研究组 & 干预措施

MRI/Ultrasound Fusion Saturation Biopsy

Experimental

干预措施: MRI/Ultrasound Fusion Saturation Biopsy (Procedure)

结局指标

主要结局

The significant prostate cancer detection rate with different combinations of core number and location in the targeted saturated biopsy area

时间窗: When histology results available, at an expected average of 3 days post-biopsy

次要结局

未报告次要终点

研究者

发起方
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hongqian Guo

Executive officer of Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

研究点 (1)

Loading locations...

相似试验